These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
191 related articles for article (PubMed ID: 38296804)
21. Efficacy and Safety of Febuxostat Extended and Immediate Release in Patients With Gout and Renal Impairment: A Phase III Placebo-Controlled Study. Saag KG; Becker MA; Whelton A; Hunt B; Castillo M; Kisfalvi K; Gunawardhana L Arthritis Rheumatol; 2019 Jan; 71(1):143-153. PubMed ID: 30073793 [TBL] [Abstract][Full Text] [Related]
24. Treatment of refractory crystal-associated arthritis. Rosenthal AK; Ryan LM Rheum Dis Clin North Am; 1995 Feb; 21(1):151-61. PubMed ID: 7732165 [TBL] [Abstract][Full Text] [Related]
25. A treat-to-target approach for gout confers renoprotective effect in patients with chronic kidney disease stage 3. Novella-Navarro M; Cabrera-Alarcon JL; Diaz-Torne C; Aramburu-Muñoz F; Janta I; Ortega de la O MC; Prada-Ojeda A; Sala-Icardo L; Urruticoechea-Arana A; García de la Peña Lefebvre P; Calvo-Aranda E Rheumatol Int; 2020 Jul; 40(7):1081-1087. PubMed ID: 31982955 [TBL] [Abstract][Full Text] [Related]
26. Molecular mechanisms of pain in crystal-induced arthritis. Ramonda R; Oliviero F; Galozzi P; Frallonardo P; Lorenzin M; Ortolan A; Scanu A; Punzi L Best Pract Res Clin Rheumatol; 2015 Feb; 29(1):98-110. PubMed ID: 26267004 [TBL] [Abstract][Full Text] [Related]
27. Renal safety and urate-lowering efficacy of febuxostat in gout patients with stage 4-5 chronic kidney disease not yet on dialysis. Kim SH; Lee SY; Kim JM; Son CN Korean J Intern Med; 2020 Jul; 35(4):998-1003. PubMed ID: 30959584 [TBL] [Abstract][Full Text] [Related]
28. Crystal arthritides - gout and calcium pyrophosphate arthritis : Part 3: Treatment. Schlee S; Bollheimer LC; Bertsch T; Sieber CC; Härle P Z Gerontol Geriatr; 2018 Aug; 51(6):703-710. PubMed ID: 28246893 [TBL] [Abstract][Full Text] [Related]
30. Colchicine prophylaxis is associated with fewer gout flares after COVID-19 vaccination. Lu J; He Y; Terkeltaub R; Sun M; Ran Z; Xu X; Wang C; Li X; Hu S; Xue X; Yan F; Zhang H; Yin H; Shi Y; Dalbeth N; Li C Ann Rheum Dis; 2022 Aug; 81(8):1189-1193. PubMed ID: 35277390 [TBL] [Abstract][Full Text] [Related]
31. A new perspective on the pharmacoeconomics of colchicine. Wertheimer AI; Davis MW; Lauterio TJ Curr Med Res Opin; 2011 May; 27(5):931-7. PubMed ID: 21370937 [TBL] [Abstract][Full Text] [Related]
32. Zhengqing fengtongning sustained-release tablets prevents gout flares in the process of ULT: A randomized, positive control, double-blind, double-simulation, multicenter trial. Jia E; Hu S; Geng H; Zhu H; Xie J; Xiao Y; Jiang Y; Xiao M; Zhang J Medicine (Baltimore); 2022 May; 101(18):e29199. PubMed ID: 35550468 [TBL] [Abstract][Full Text] [Related]
33. [Update on Gout and Calcium pyrophosphate deposition (CPPD)]. Reuss-Borst M; Tausche AK Dtsch Med Wochenschr; 2018 Aug; 143(16):1157-1166. PubMed ID: 30086561 [TBL] [Abstract][Full Text] [Related]
34. Colchicine: its mechanism of action and efficacy in crystal-induced inflammation. Nuki G Curr Rheumatol Rep; 2008 Jul; 10(3):218-27. PubMed ID: 18638431 [TBL] [Abstract][Full Text] [Related]
35. Open-label randomised pragmatic trial (CONTACT) comparing naproxen and low-dose colchicine for the treatment of gout flares in primary care. Roddy E; Clarkson K; Blagojevic-Bucknall M; Mehta R; Oppong R; Avery A; Hay EM; Heneghan C; Hartshorne L; Hooper J; Hughes G; Jowett S; Lewis M; Little P; McCartney K; Mahtani KR; Nunan D; Santer M; Williams S; Mallen CD Ann Rheum Dis; 2020 Feb; 79(2):276-284. PubMed ID: 31666237 [TBL] [Abstract][Full Text] [Related]
36. Prevalence and incidence of non-gout crystal arthropathy in southern Sweden. Hameed M; Turkiewicz A; Englund M; Jacobsson L; Kapetanovic MC Arthritis Res Ther; 2019 Dec; 21(1):291. PubMed ID: 31847885 [TBL] [Abstract][Full Text] [Related]
37. A Randomized, Phase II Study Evaluating the Efficacy and Safety of Anakinra in the Treatment of Gout Flares. Saag KG; Khanna PP; Keenan RT; Ohlman S; Osterling Koskinen L; Sparve E; Åkerblad AC; Wikén M; So A; Pillinger MH; Terkeltaub R Arthritis Rheumatol; 2021 Aug; 73(8):1533-1542. PubMed ID: 33605029 [TBL] [Abstract][Full Text] [Related]
38. Oral colchicine (Colcrys): in the treatment and prophylaxis of gout. Yang LP Drugs; 2010 Aug; 70(12):1603-13. PubMed ID: 20687623 [TBL] [Abstract][Full Text] [Related]
39. The role of Interleukin-1 receptor antagonist as a treatment option in calcium pyrophosphate crystal deposition disease. Altomare A; Corrado A; Maruotti N; Cici D; Cantatore FP Mol Biol Rep; 2021 May; 48(5):4789-4796. PubMed ID: 34075537 [TBL] [Abstract][Full Text] [Related]